Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Obesity × Diazoxide × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Endocrine 1 CNS 1

Conditions

Pituitary Diseases 1 Obesity 1 Neoplasms 1 Hypoglycemia 1 Hyperinsulinism 1 Gastro-enteropancreatic neuroendocrine tumor 1 Craniopharyngioma 1

Interventions

Exercise 4 Diet 3 Standard of Care 1 Palliative Care 1 Observation 1 Nutrition Assessment 1 Exercise Test 1 Diet, Carbohydrate-Restricted 1 Diazoxide 1 Blood Specimen Collection 1 Adrenalectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00306683 2011-02-18

Effect of Diazoxide on the Obesity Secondary to Hypothalamic-pituitary Lesions

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed

CNSEndocrineOther

Craniopharyngioma, Hyperinsulinism, Neoplasms, Obesity, Pituitary Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡